tiprankstipranks

Lifecare ASA Achieves Breakthrough in Glucose Sensor Sensitivity

Story Highlights
Lifecare ASA Achieves Breakthrough in Glucose Sensor Sensitivity

The latest announcement is out from Lifecare AS ( (DE:LFC0) ).

Lifecare ASA has announced a significant advancement in its glucose sensor technology, achieving a fivefold improvement in sensitivity through its new proprietary chemistry. This enhancement is expected to improve the accuracy and precision of glucose monitoring, offering superior performance compared to current market options and simplifying manufacturing and algorithm processes, ensuring a better user experience and product reliability.

More about Lifecare AS

Lifecare ASA is a clinical stage medical sensor company focused on developing technology for sensing and monitoring various body analytes. It aims to bring next-generation Continuous Glucose Monitoring (CGM) systems to the market, utilizing osmotic pressure as a sensing principle combined with Nano-granular Tunnelling Resistive sensors for precise readings.

YTD Price Performance: 6.06%

Average Trading Volume: 238

Technical Sentiment Consensus Rating: Buy

Current Market Cap: €16.8M

For an in-depth examination of LFC0 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App